申请人:University of Leicester
公开号:US20140309193A1
公开(公告)日:2014-10-16
There are provided inter alia compounds of formula (I) wherein R
1
, R
2
, R
3
, R
4a
and R
4b
are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
其中提供了式(I)的化合物,其中R1、R2、R3、R4a和R4b如规范中定义,并且它们在治疗中的使用,特别是在治疗细菌(例如肺炎球菌)感染方面。